Canaccord Genuity Downgrades RTI Biologics (RTIX) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
RTI Surgical (RTIX) Reports In-Line Q3 EPS; Trims FY15 Outlook
October 29, 2015 9:09 AM EDTRTI Surgical (NASDAQ: RTIX) reported Q3 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $66.5 million versus the consensus estimate of $69.53 million.
RTI Surgical sees FY2015 EPS of $0.19, versus prior guidance of $0.20-$0.23 and the consensus of... More
